Results 241 to 250 of about 3,750,719 (375)
A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye. [PDF]
Akgun A, Tas I.
europepmc +1 more source
Toxicological analyses of the bone matrix: Successes and challenges
Abstract This study aimed to conduct an in‐depth and systematic literature review dealing with toxicological analyses on human bone tissue and focusing on the forensic toxicological and archaeotoxicological field. Several studies have focused their research on medical drugs, drugs of abuse, and trace elements on both human cadavers and skeletal remains,
Gaia Giordano+3 more
wiley +1 more source
ABSTRACT Introduction Inpatient depression is associated with high morbidity and significant cognitive impairment. Inpatient treatment often focuses on short‐term stabilization with medication. Readmission rates are high. We examined the impact of a novel psychological intervention, activation therapy (AT, Behavioural Activation combined with Cognitive
Katie M. Douglas+9 more
wiley +1 more source
The potential of dibenzazepine carboxamides in cancer therapy. [PDF]
Afsordeh N+3 more
europepmc +1 more source
Anticonvulsant drugs, brain glutamate dehydrogenase activity and oxygen consumption. [PDF]
Vega Rasgado LA+2 more
europepmc +1 more source
Patient experiences of behavioural therapy for bipolar depression: A qualitative study
Abstract Background Although multiple qualitative studies have explored participants' experiences of behavioural activation (BA) for unipolar depression, none have investigated the experiences of BA in people with bipolar depression. This is of particular interest because qualitative studies concerning the experience of receiving therapy can help ...
Sakir Yilmaz+6 more
wiley +1 more source
Twenty-four years of prescription patterns in bipolar disorder inpatients with vs without lithium: a pharmacoepidemiological analysis of 8,707 cases in German-speaking countries. [PDF]
Greil W+9 more
europepmc +1 more source
CCR5 predicts neurotoxicity in CAR‐T‐cell therapy
Patients undergoing chimeric antigen receptor T (CAR T)‐cell therapy are at risk of developing immune effector cell‐associated neurotoxicity syndrome (ICANS). We observed an upregulation of CCR5 and CCR2 expression in CD4+ T cells among patients who developed ICANS.
Ayal Rozenberg+12 more
wiley +1 more source